Ubrogepant and Nevirapine: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Nevirapine
Ubrogepant
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Decreased ubrogepant exposure
Interaction Deep Dive
Concomitant use of ubrogepant with this drug (a moderate or weak CYP3A inducer) may decrease ubrogepant exposure, which may lead to reduced efficacy. If concomitant use is necessary, the initial ubrogepant dose should be 100 mg, and if necessary, a second 100-mg dose at least 2 hours after the initial dose1.
Why it happens (mechanism)
Induction of CYP3A-mediated ubrogepant metabolism
Literature reports
1 report — tap to read
a) Concomitant use of ubrogepant with rifampin (a strong CYP3A inducer) resulted in an 80% reduction in ubrogepant exposure 1.
Common questions
Can I take Ubrogepant and Nevirapine together?
Decreased ubrogepant exposure Always confirm with your pharmacist or prescriber before making any change.
How serious is the Ubrogepant and Nevirapine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Ubrogepant or Nevirapine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: UBRELVY(TM) oral tablets, ubrogepant oral tablets. Allergan USA Inc (per FDA), Madison, NJ, 2019. DailyMed
Keep reading about Nevirapine
Keep reading about Ubrogepant
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist